SK Discovery launches bio strategy, investment division
The move will boost cooperation and synergy among the chemical company's bio affiliates
By Dec 06, 2022 (Gmt+09:00)
Macquarie eyes its 1st Korean data center valued around $722 mn
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
S.Korea's LS Materials set to boost earnings ahead of IPO process
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
POSCO gears up for carbon-free steelmaking with hydrogen
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Galaxy Ring, new foldables set to steal the show at Samsung Unpacked Paris
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
![SK Discovery launches bio strategy, investment division](https://www.kedglobal.com/data/ked/image/2022/12/06/ked202212060015.700x.0.jpg)
Korea's chemical company SK Discovery Co. on Tuesday said it launched a bio strategy and investment division headed by Kim Jung-hoon, director of SK Chemicals' R&D center.
The new division will search for new business opportunities for SK Discovery's bio affiliates under the goal of creating horizontal expansion and a synergistic effect through inter-subsidiary collaboration.
A pharmaceutical and bio expert who joined SK Chemicals in 1998 after graduating from the College of Pharmacy at Seoul National University, Kim is experienced in leading overseas business, marketing and R&D organizations at the company.
"SK Discovery's bio affiliates have growth engines thanks to their outstanding human resources and business portfolios," Kim said. "The Bio Strategy and Investment Division will assume a role in fueling each affiliate's growth and creating a synergistic effect."
Write to Jeong Min Nam at peux@hankyung.com
-
Bio & PharmaSK Biopharma's epilepsy treatment posts impressive growth in US
Nov 11, 2022 (Gmt+09:00)
1 Min read -
COVID-19SK Bioscience seeks WHO nod for prompt COVID vaccine sale
Sep 08, 2022 (Gmt+09:00)
1 Min read -
Bio & PharmaSK Discovery to control affiliates’ entire biotechnology business
Aug 05, 2022 (Gmt+09:00)
2 Min read -
Corporate investmentSK takes aim at chips, batteries, bio with $195 billion investment
May 26, 2022 (Gmt+09:00)
3 Min read